Business Model Canvas

Prepared by-Asgar Hussain Inamdar

Hetero Healthcare Pvt. Ltd.

Hetero Drugs Limited is an

Indian Pharmaceutical Company established in the

year 1993. Hetero Drugs Limited founded by Dr. B.
Partha Saradhi Reddy Phd., a scientist and expert in
chemistry. It was started by him with a vision to be
recognised as an aggressive company that combines
its strength of R&D and manufacturing with definite
advantages in terms of cost and chemistry with a
strong emphasis on Quality of the products.

Key Resources
Intellectual resources
Licenses, patents, industrial properties (owned or leased by Hetero)

Human resources
Scientists
researchers
Students

Physical
Local implantations worldwide (laboratories, agences, local manufacturing in
emerging markets )

Financial resources
Investors

Key Activities
To develop products and licensing

Scientists and developers all around the world through Medical institutes such as
Salk
Research centers (R&D institutes) & Medical centers
Institutes of science / technology
research and development companies in health field
biopharmaceutical companies
Pharmaceutical companies
Laboratories
Healthy foundation
To communicate via sponsoring, co promotion and co marketing
To sell : commercialization agreement in specific regions

Laboratories
Commercial agents

Key Partners
Global health group is engaged in research, development, manufacture and

marketing of healthcare products. The main activities according their

importance and their turnover are:

Pharmaceuticals (prescription drugs, consumer health, general medicine):

aging diabetes, rare diseases, oncology and other important products in the
prevention of thrombosis, cardiovascular disease, nephrology and
biosurgery.

R&D to prevent, treat and cure disease. Constant innovation is very

important in order to attain his goal: answer to the real needs of patients
and provide them appropriate therapeutic solutions

Key Partners
Clinical Development

Marketing & Distribution

Creating value through partnerships

Availability and performance of drug

Value Creation
Creating Value by providing quality and potential

medicines.
Cost Effective Medicines.
Medicines with high potential and low reaction

period.
Availaibility of Products in market.

Value Proposition
A leading position in the Indian pharmaceutical industry

- vaccines, biologicals and in small molecules.

Many investment in R & D and innovative partnerships

to research and deliver the best treatments.

Premium brands like Hifen, Opox, Levocet, Lazin.

Taking into account local needs

Regional strategy and pricing

Customer Channels
Communication through Medical Institutions :

hospitals, pharmacies, health personnel (doctors)

Communication through a website
heterohealthcare.com and social media as Facebook,
Twitter, Android,iPhone and iPad app, YouTube
Channels.
Hetero Healthcare has also develop a wide network of

industrial sites.Commercial presence in the

world.Multiple acquisitions and parternships.

Customer Segment

Physical
Patients
Health professionals: doctors, hospitals, pharmaceutical customer.
Offer training and services: Hetero assists health professionals throughout their careers
and in the evolution of their profession
General public: self medication (one of the growth platforms for Hetero)
Veterinarians, farmers and pet owners
Universities and students (through training)
Worldwide connected network of selected partners

Customer Segment
Geographical

Patients around the world

Present in 100 countries and its products are
distributed in more than 170 countries
Hetero is recognized in Emerging Markets, with
excellent positions in major countries.

Customer Relationship

Innovation with the Doctors:

Conference calls and Interactive learning sessions.

Website
Destinated to all their clients worldwide, it helps
Hetero Healthcare to defend a healthcare and public
utility image.
Customer relationship is externalized:

Cost Structure
R&D is NOT the main cost item :

They try to optimise their ressources allocation in order to

maximize the R&D return on investment

Partnerships and Acquisitions:

Investment for 26 new transactions (8 acquisitions and 18

partnerships in R&D)
Sales Force is the 1st cost item:
Re-allocation by region and by products (less expenses on
traditionnal products but more on innovative ones)

Cost Structure

Administrative and General charges:

Methodological following of these costs

Communication and Publicity:

By definition publicity is free and better for the companys image

Ex: Press articles on the last Heteros innovation which will be able to cure a
rare diseases.

In emerging market the main cost are:

Purchase of raw material

Energy consumption of the laboratories
Work force

Revenue Streams
Asset Sales type of revenue-

Hetero provides innovatives products and

communication related to those new medicines. The
company contributes to the medicines promotion by
the States.
Worldwide Net Turnover Shares : Domestic Market76%,International Market-24%